ACTOPRIL

Brand name authorized in: Tunisia

Active ingredients

The drug ACTOPRIL contains one active pharmaceutical ingredient (API):

1 Captopril
UNII 9G64RSX1XD - CAPTOPRIL

Captopril is a highly specific, competitive inhibitor of angiotensin-I converting enzyme (ACE inhibitors). Inhibition of ACE results in decreased plasma angiotensin-II, which leads to decreased vasopressor activity and to reduced aldosterone secretion. In patients with hypertension, captopril causes a reduction in supine and erect blood pressure, without inducing any compensatory increase in heart rate, nor water and sodium retention.

Read about Captopril

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Captopril
C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA01

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
TN
Direction de la Pharmacie et du M├ędicament
Identifier(s): 9293111, 9293112, 9293113H, 9293114H, 9293115